- Eli Lilly’s Antibody Trial Is Paused Over Potential Safety Concern. The drugmaker’s experimental antibody treatment is similar to the one President Trump received from Regeneron. https://www.nytimes.com/2020/10/13/health/covid-antibodies-eli-lilly-paused.html 3 comments worldnews
Linking pages
Linked pages
- The Covid-19 Pandemic - The New York Times https://www.nytimes.com/news-event/coronavirus?action=click&%3Bmodule=spotlight&%3Bpgtype=homepage 9 comments
- Covid in the U.S.: Latest Maps, Case and Death Counts - The New York Times https://www.nytimes.com/interactive/2021/us/covid-cases.html 8 comments
- President Trump Received Regeneron Experimental Antibody Treatment - The New York Times https://www.nytimes.com/2020/10/02/health/trump-antibody-treatment.html 7 comments
- Why the Odds Are Stacked Against a Promising New Covid Drug - The New York Times https://www.nytimes.com/2023/02/08/health/covid-drug-eiger-interferon.html 1 comment
Related searches:
Search whole site: site:www.nytimes.com
Search title: Eli Lilly’s Antibody Trial Is Paused Over Potential Safety Concern - The New York Times
See how to search.